The total return for Waters Corporation (WAT) stock is +6.56% over the past 12 months vs. +24.34% for the S&P 500. So far it's up -2.29% this year. Includes price appreciation + reinvested dividends.
Waters Corporation (WAT) Compound Annual Growth Rates (CAGR) Summary
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +6.56% | +14.18% | +2.50% | +10.24% | +9.57% | +11.38% |
| Total Return CAGR | +6.56% | +14.18% | +2.50% | +10.24% | +9.57% | +11.38% |
| Revenue CAGR | +25.93% | +8.30% | +8.48% | +6.24% | +5.44% | +5.98% |
| Net Income CAGR | (31.22%) | (13.24%) | (6.12%) | (0.39%) | +0.76% | +4.14% |
| EPS CAGR | +0.47% | (2.91%) | +5.16% | +6.60% | +6.62% | +9.46% |
| Free Cash Flow CAGR | (56.80%) | (15.17%) | (17.63%) | (5.39%) | (2.86%) | +0.32% |
| Operating Cash Flow CAGR | (48.07%) | (13.84%) | (14.57%) | (3.65%) | (1.34%) | +1.39% |
| Dividends CAGR | - | - | - | - | - | - |
CAGR Trends History
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
WAT Total Return CAGR Chart
Waters Corporation (WAT)
Annual Total Returns Comparison
| Year | Start Value | End Value | WAT Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | 5582.92 | 5455.33 | (2.29%) | +8.38% | (10.67%) |
| 2025 | 5452.84 | 5582.92 | +2.39% | +17.72% | (15.33%) |
| 2024 | 4839.17 | 5452.84 | +12.68% | +24.89% | (12.21%) |
| 2023 | 5035.40 | 4839.17 | (3.90%) | +26.19% | (30.09%) |
| 2022 | 5476.65 | 5035.40 | (8.06%) | (18.17%) | +10.11% |
| 2021 | 3636.69 | 5476.65 | +50.59% | +28.74% | +21.85% |
| 2020 | 3434.30 | 3636.69 | +5.89% | +18.37% | (12.48%) |
| 2019 | 2772.86 | 3434.30 | +23.85% | +31.22% | (7.37%) |
| 2018 | 2839.60 | 2772.86 | (2.35%) | (4.56%) | +2.21% |
| 2017 | 1975.33 | 2839.60 | +43.75% | +21.70% | +22.05% |
About Waters Corporation
Waters Corporation is a global leader in specialized measurement, delivering analytical solutions across Asia, the Americas, and Europe. The company operates through two main divisions: Waters and TA. Under its Waters segment, it engineers, manufactures, sells, and provides support for high and ultra-performance liquid chromatography and mass spectrometry (MS) systems. This includes essential consumables like chromatography columns and comprehensive post-warranty service plans. The TA segment focuses on designing, producing, selling, and servicing instruments for thermal analysis, rheometry, and calorimetry. Additionally, Waters develops and supplies sophisticated software that integrates with both its own instruments and those from other manufacturers. The company's advanced MS technology plays a crucial role in various applications, such as drug discovery and development (including clinical trial assessments), analyzing proteins involved in disease processes, ensuring nutritional safety, and conducting environmental testing. Its thermal analysis, rheometry, and calorimetry instruments are vital for assessing the suitability and stability of a wide range of materials, including fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids. These instruments support diverse sectors like industrial manufacturing, consumer goods, healthcare products, and life science research. Waters' extensive client base spans the life sciences, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental sectors, where its products are instrumental in research and development, quality assurance, and general laboratory operations. Established in 1958, Waters Corporation is headquartered in Milford, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Udit Batra